Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Immedica Pharma AB

Closing information (x1000 NOK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 917,236 Less Arrow 576,611 Less Arrow 482,704
Financial expenses 72,208 More Arrow 72,998 Less Arrow 41,777
Earnings before taxes 84,665 Less Arrow 30,845 More Arrow 54,483
EBITDA 235,987 Less Arrow 176,710 More Arrow 202,982
Total assets 2,254,869 Less Arrow 1,454,806 Less Arrow 1,178,164
Current assets 594,555 Less Arrow 326,752 Less Arrow 307,043
Current liabilities 340,123 Less Arrow 160,302 Less Arrow 111,305
Equity capital 840,981 Less Arrow 623,594 Less Arrow 452,351
- share capital 51 Less Arrow 47 More Arrow 49
Employees (average) 88 Less Arrow 69 Less Arrow 52

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 37.3% More Arrow 42.9% Less Arrow 38.4%
Turnover per employee 10,423 Less Arrow 8,357 More Arrow 9,283
Profit as a percentage of turnover 9.2% Less Arrow 5.3% More Arrow 11.3%
Return on assets (ROA) 7.0% More Arrow 7.1% More Arrow 8.2%
Current ratio 174.8% More Arrow 203.8% More Arrow 275.9%
Return on equity (ROE) 10.1% Less Arrow 4.9% More Arrow 12.0%
Change turnover 299,711 Less Arrow 108,415 Less Arrow 75,101
Change turnover % 49% Less Arrow 23% Less Arrow 18%
Chg. No. of employees 19 Less Arrow 17 Less Arrow 8
Chg. No. of employees % 28% More Arrow 33% Less Arrow 18%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.